Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

AstraZeneca, Daiichi Will Seek Approval Following ADC Trial Success In Advanced Breast Cancer

Wed, 05/08/2019 - 9:38am

AstraZeneca and Daiichi said their pivotal Phase II DESTINY-Breast01 trial assessing the HER2-targeting antibody drug conjugate trastuzumab deruxtecan met its primary...

      Related Stories 

All To Play For: CAR-T Specialist Celyad’s Big Year

Wed, 05/08/2019 - 8:02am

Celyad’s leadership team talks to Scrip about the critical nature of the coming months for its lead cancer therapy product...

      Related Stories 

Manufacturing Part Of GSK Proposal For Single Dose Antimalarial In India

Wed, 05/08/2019 - 7:28am

GlaxoSmithKline has proposed to market and manufacture antimalarial Krintafel in India and an expert panel has sought additional information to...

      Related Stories 

Why BI Bid Farewell To Biosimilars

Wed, 05/08/2019 - 5:58am

The German group pharma's chief told Scrip "innovation drives the business" and confirmed that biosimilars have been abandoned apart from...

      Related Stories 

All Eyes On Early Post-Shire Performance Ahead Of Takeda Q4

Tue, 05/07/2019 - 10:28pm

The first real indications of how Shire is contributing to Takeda will come when the Japanese firm issues its annual...

      Related Stories 

Finance Watch: A One-Time Treatment For Heart Disease? Verve Raises $58.5m To Give It A Try

Tue, 05/07/2019 - 3:34pm

Private Company Edition: With academic muscle, Google cash and nanoparticles, and various CRISPR licenses, Verve will develop gene-editing therapies for...

      Related Stories 

BioMarin Expands PKU Dominion With EU Approval Of Palynziq

Tue, 05/07/2019 - 12:53pm

Palynziq has received European Commission approval to treat phenylketonuria a year after the US FDA gave it the green light...

      Related Stories 

Mylan New Launches On Track For $1bn In 2019, But It's Not Enough

Tue, 05/07/2019 - 12:18pm

New complex generic and biosimilar launches like Wixela, Fulphila and generic Copaxone generated $250m in the first quarter, but the...

      Related Stories 

Confo Therapeutics Raises €30m Series A To Drug Difficult Targets

Tue, 05/07/2019 - 12:01am

Belgian drug discovery company raises funds to finance development of its platform to discover compounds targeting difficult-to-drug GPCRs and advance...

      Related Stories 

Asian Investors Bankroll €40m Promethera Biosciences Series D

Mon, 05/06/2019 - 10:28pm

Liver disease-focused Belgian cell therapy biotech Promethera Biosciences closes a €39.7m ($44.4m) Series D round co-led by new Japanese investors...

      Related Stories 

Cytokinetics Sees Enough Evidence To Move Reldesemtiv Into Phase III For ALS

Mon, 05/06/2019 - 8:09pm

The Astellas-partnered drug did not reach statistical significance on any FORTITUDE-ALS endpoints, but clinically significant results over time justify a...

      Related Stories